Sebastian Stintzing, MD, Professor of Medicine, is Head of the Department of Hematology, Oncology, and Tumor Immunology (CCM) of Charité Universitaetsmedizin, Berlin. His research focuses on predictive and prognostic biomarkers in the treatment of gastrointestinal cancer. In 2012, he received the prestigious Research Fellowship Award from the “Deutsche Krebshilfe” (German Cancer Aid) in Bonn, Germany, enabling him to work as a research fellow at the Sharon Carpenter Laboratory at the USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA (Prof H.-J. Lenz). He coordinated the translational part and assisted the clinical study conduct of several studies (AIO KRK-0104, AIO KRK-0306, AIO KRK-0110, AIO KRK-0114). In 2014, he received the scientific award of the AIO (working group of medical oncology within the German Cancer Society). Professor Stintzing is member of several national and international cancer associations (ESMO, ASCO, and DGHO). Furthermore, he is speaker of the working group “Colorectal Carcinoma” (since 2019) and a member of the steering committee of the working group “Translational Research” (since 2017) of the German AIO (working group of medical oncology). Since 2014, he is member of the S3-guideline committee for colorectal cancer in Germany.